DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Tyramine is an investigational drug.
There have been 16 clinical trials for Tyramine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 2nd 2018.
The most common disease conditions in clinical trials are Hypercholesterolemia, Hyperlipoproteinemia Type II, and Depressive Disorder. The leading clinical trial sponsors are Sanofi, Regeneron Pharmaceuticals, and Boehringer Ingelheim.
Recent Clinical Trials for Tyramine
|A Study of the Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome||Pharmascience Inc.||Phase 2|
|A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood Pressure||Boehringer Ingelheim||Phase 1|
|Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy||Zagazig University||N/A|